Z-0341-2023 Class II Terminated
FDA device recall Z-0341-2023 was initiated by Cytocell Ltd. on Oct 27, 2022 and is designated Class II. Reason for recall: An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong… The recall status is terminated (terminated Dec 27, 2024). Affected quantity: 3 units.
Recall details
- Product Type
- Devices
- Report Date
- Dec 7, 2022
- Initiation Date
- Oct 27, 2022
- Termination Date
- Dec 27, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 units
Product description
CytoCell BCL11B Distal in Texas Red Spectrum- Analyte Specific Reagent Ref: MPD39782
Reason for recall
An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong coordinates.
Distribution pattern
TX
Code information
Lot Number: RD22/230/11
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0341-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026